[go: up one dir, main page]

DK0585355T3 - Flerlagspræparat med reguleret frigivelse - Google Patents

Flerlagspræparat med reguleret frigivelse

Info

Publication number
DK0585355T3
DK0585355T3 DK92912145.7T DK92912145T DK0585355T3 DK 0585355 T3 DK0585355 T3 DK 0585355T3 DK 92912145 T DK92912145 T DK 92912145T DK 0585355 T3 DK0585355 T3 DK 0585355T3
Authority
DK
Denmark
Prior art keywords
controlled release
release preparation
sustainably
multilayer controlled
periphery
Prior art date
Application number
DK92912145.7T
Other languages
English (en)
Inventor
Hiroyuki Yoshino
Yoshiyuki Hirakawa
David D Maclaren
Paul F Skultety
John R Lefler
Greg M Beck
Kazuo Noda
Original Assignee
Tanabe Seiyaku Co
Marion Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co, Marion Laboratories Inc filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of DK0585355T3 publication Critical patent/DK0585355T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92912145.7T 1991-05-20 1992-05-20 Flerlagspræparat med reguleret frigivelse DK0585355T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70285491A 1991-05-20 1991-05-20

Publications (1)

Publication Number Publication Date
DK0585355T3 true DK0585355T3 (da) 1995-06-06

Family

ID=24822867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92912145.7T DK0585355T3 (da) 1991-05-20 1992-05-20 Flerlagspræparat med reguleret frigivelse

Country Status (11)

Country Link
US (1) US5320853A (da)
EP (1) EP0585355B1 (da)
JP (1) JP3426230B2 (da)
AT (1) ATE120089T1 (da)
AU (1) AU2016992A (da)
DE (1) DE69201793T2 (da)
DK (1) DK0585355T3 (da)
ES (1) ES2073301T3 (da)
GR (1) GR3015737T3 (da)
NZ (1) NZ242806A (da)
WO (1) WO1992020326A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU653026B2 (en) * 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5645858A (en) * 1994-10-06 1997-07-08 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US6156343A (en) * 1994-12-27 2000-12-05 Akzo Nobel N.V. Controlled release preparation
US5834024A (en) 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
FR2754177B1 (fr) * 1996-10-07 1999-08-06 Sanofi Sa Microspheres pharmaceutiques d'acide valproique pour administration orale
US5885616A (en) * 1997-08-18 1999-03-23 Impax Pharmaceuticals, Inc. Sustained release drug delivery system suitable for oral administration
US6602521B1 (en) 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
CN102716101A (zh) 1999-10-29 2012-10-10 欧罗赛铁克股份有限公司 控释氢可酮制剂
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AU2882201A (en) * 2000-01-27 2001-08-07 Tanabe Seiyaku Co., Ltd. Sustained-release preparation and process for producing the same
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
CN100518827C (zh) 2000-10-30 2009-07-29 欧罗赛铁克股份有限公司 控释氢可酮制剂
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
GB0310919D0 (en) * 2003-05-13 2003-06-18 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
ES2228267B1 (es) * 2003-07-30 2006-07-01 Laboratorios Del Dr. Esteve, S.A. Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
ES2228268B1 (es) * 2003-07-30 2006-07-01 Laboratorios Del Dr. Esteve, S.A. Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
JP4468669B2 (ja) * 2003-09-22 2010-05-26 久光製薬株式会社 低刺激性貼付剤
DE10353186A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
DE10353196A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
AU2005266459A1 (en) * 2004-07-29 2006-02-02 Sanofi-Aventis Pharmaceutical multilayer tablet for controlled release of active ingredients with highly pH-dependent solubility
PT1836665E (pt) 2004-11-19 2013-04-11 Glaxosmithkline Llc Método para fornecimento personalizado de produtos de combinação de medicamentos em doses variáveis para individualização de terapêuticas
JP5433236B2 (ja) * 2006-01-27 2014-03-05 アプタリス ファーマテック，インコーポレイテッド 弱塩基性選択性セロトニン５−ｈｔ３遮断剤および有機酸を含む薬物送達系
JP5787301B2 (ja) * 2006-01-27 2015-09-30 アデア ファーマシューティカルズ，インコーポレイテッド 弱塩基性薬および有機酸を含む薬物送達系
US20080181932A1 (en) * 2007-01-30 2008-07-31 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
CA3013149C (en) 2007-03-13 2021-12-07 Jds Therapeutics, Llc Methods and compositions for the sustained release of chromium
US8679541B2 (en) * 2007-03-14 2014-03-25 Particle Dynamics International, Llc Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals
US8623397B2 (en) * 2007-04-13 2014-01-07 The Regents Of The University Of Michigan Delivery device and method for forming the same
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
MX2018009748A (es) 2016-02-11 2019-02-07 Nutrition 21 Llc Composiciones que contienen cromo para mejorar la salud y el estado físico.
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB768512A (en) * 1954-08-16 1957-02-20 Smith Kline & French Internat Improvements in or relating to pharmaceutical tablets
GB874586A (en) * 1957-10-28 1961-08-10 Upjohn Co Improvements in or relating to therapeutic compositions and the manufacture thereof
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
GB1346610A (da) * 1971-07-02 1974-02-13
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
DE2802114A1 (de) * 1978-01-19 1979-07-26 Sandoz Ag Neue pharmazeutische zusammensetzung und verfahren zu deren herstellung
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE2950977A1 (de) * 1978-12-22 1980-07-10 Donald E Panoz Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
IE56459B1 (en) * 1983-12-21 1991-08-14 Elan Corp Ltd Controlled absorption pharmaceutical formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
JPS615010A (ja) * 1984-06-18 1986-01-10 Tooa Eiyoo Kk 水素添加麦角アルカロイド徐放性製剤及びその製法
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US4826688A (en) * 1985-11-13 1989-05-02 501 Elan Corporation PLC. Controlled absorption pharmaceutical formulation
AU615221B2 (en) * 1987-10-16 1991-09-26 Elan Corporation, Plc Controlled absorption diltiazem formulations
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
FI101344B (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseut tisesti aktiivista ainetta
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法

Also Published As

Publication number Publication date
WO1992020326A1 (en) 1992-11-26
JPH06507903A (ja) 1994-09-08
DE69201793T2 (de) 1995-09-21
US5320853A (en) 1994-06-14
AU2016992A (en) 1992-12-30
NZ242806A (en) 1994-01-26
JP3426230B2 (ja) 2003-07-14
EP0585355A1 (en) 1994-03-09
GR3015737T3 (en) 1995-07-31
EP0585355B1 (en) 1995-03-22
ATE120089T1 (de) 1995-04-15
ES2073301T3 (es) 1995-08-01
DE69201793D1 (de) 1995-04-27

Similar Documents

Publication Publication Date Title
DK0585355T3 (da) Flerlagspræparat med reguleret frigivelse
NO864243D0 (no) Flerlags granuler og fremgangsmaate for deres fremstilling.
ITMI942484A0 (it) Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione
NO2007003I2 (no) Maropitant eller et farmasøytisk akseptabelt salt av denne forbindelsen, inkludert citrat monohydratsalt
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
DE69842173D1 (de) Neue Suppositoriumsform mit säureempfindlichem Wirkstoff
DE69233776D1 (de) Verwendung einer 1,3 Oxathiolannukleosid-analogen Verbindung zur Herstellung eines Arzneimittels zur spezifischen Verabreichung
NO904492L (no) Fremgangsmaate for fremstilling av et aerosolpreparat for topisk anvendelse.
ES531592A0 (es) Procedimiento para el montaje de un tope de desembrague
SE9704869D0 (sv) New pharmaceutical formulaton II
NO911934L (no) Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner.
MX9200374A (es) Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene.
EE200100172A (et) Tetrahüdropüridoeetrid, nende kasutamine ja ravim
FI891407A0 (fi) Anordning foer svaellning av naeringsaemnen, njutningsmedel och liknande.
NO893616D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser.
MX9207115A (es) Nuevos derivados imidazopiridinas, procedimiento para su fabricacion, preparado farmaceutico que los contiene y procedimiento para la fabricacion de dicho preparado farmaceutico
IS1664B (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandiog kvalastillandi áhrif
FI881191A0 (fi) Kompakt maskin foer framstaellning av cigarretter.
ATE209627T1 (de) Schlüsselzwischenprodukte zur herstellung von simvastatin
ES2059464T3 (es) Formas especificamente dirigidas de agentes antitumorales de metiltritio.
MX9201847A (es) Derivados heterociclicos de antiserotoninas, procedimiento para su preparacion y medicamentos que los contienen.
FI96013B (fi) Koekstrudoitu, kaksiaksiaalisesti suunnattu monikerroskalvo
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
NO892204D0 (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO993627D0 (no) Anvendelse av en forbindelse for fremstilling av et legemiddel